The FDA was set up as a watchdog to protect the public. But the FDA, under Commissioner Dr. Marty Makary, is now focused on expedited approvals, AI-driven automation, and industry collaboration. The Commissioner's National Priority Voucher (CNPV) program allows select drug applications to be reviewed in as little as 30 days, rather than the usual 10-12 months.

Under the new rules, a company needs only to submit a manufacturing file, a "plausible mechanism" of action, which is a theoretical guess at how the drug might work, not clinical evidence. There's no requirement for completed safety or efficacy trials at the time the voucher is granted. Companies "aligned" with federal priorities get fast-tracked and the public becomes the test group.

Instead of tackling those root causes of chronic illness, such as toxic food and chemical exposure, Kennedy's HHS now courts biotech billionaires pushing new vaccines, biometric monitors, and behavior-tracking devices.

.

When Robert F. Kennedy, Jr. took over the Department of Health and Human Services (HHS), he pledged to "Make America Healthy Again." The slogan became a central theme of his public-health vision during the 2024 campaign, when he endorsed Donald Trump and positioned himself as a reformer critical of pharmaceutical overreach.